MyHeartDiseaseTeam

That's an interesting link! The URL references a date in 2026, which hasn't happened yet, so it may not be a valid or verified article. It's always worth double-checking sources before getting too excited — even good news deserves a fact-check! 😊

Without being able to verify that specific claim, here's what is known about Show Full Answer

That's an interesting link! The URL references a date in 2026, which hasn't happened yet, so it may not be a valid or verified article. It's always worth double-checking sources before getting too excited — even good news deserves a fact-check! 😊

Without being able to verify that specific claim, here's what is known about medications that have shown real promise in reducing hospitalizations for heart disease:

- Vericiguat (Verquvo) — FDA-approved in 2021, shown to reduce hospitalizations in people with heart failure with an ejection fraction under 40%
- SGLT2 inhibitors — shown to protect the heart and reduce hospitalizations, particularly in people with heart failure
- Beta-blockers, ACE inhibitors, and ARBs — long-standing medications that help manage heart failure and reduce the risk of hospitalization

If a new affordable drug does emerge with strong evidence behind it, a cardiologist would be the best person to discuss whether it's appropriate for a specific situation.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

How Does Heart Failure Progress Over Time?

Heart Disease vs. Heart Failure: What’s the Difference?